Filter
4041
Filtered Results: 4041
Text search:
rate
ratio
Featured
Recommendations
356
New Publications
1237
Language
Document type
No document type
2569
Studies & Reports
651
Guidelines
434
Manuals
141
Strategic & Response Plan
119
Training Material
51
Fact sheets
34
Situation Updates
27
Infographics
8
Resource Platforms
4
Online Courses
2
Brochures
1
Countries / Regions
India
259
Kenya
149
Global
140
Ethiopia
136
Nepal
113
South Africa
97
Nigeria
93
Rwanda
91
Uganda
90
Sierra Leone
89
Malawi
80
Myanmar / Burma
77
Zambia
75
Ghana
71
Bangladesh
71
Liberia
69
Western and Central Europe
68
Tanzania
65
Philippines
54
Africa
53
Latin America and the Carribbean
47
Zimbabwe
39
Lesotho
39
Namibia
37
Cambodia
36
Indonesia
36
Congo, Democratic Republic of
32
Eastern Europe
32
Ukraine
31
Syria
30
Asia
26
Botswana
24
Senegal
23
South–East Asia Region
22
Burkina Faso
20
Mozambique
20
Haiti
19
South Sudan
19
West and Central Africa
18
Germany
17
Eswatini/ Swaziland
17
Brazil
16
Cameroon
15
Pakistan
14
Eastern Europe and Central Asia
14
Madagascar
13
East and Southern Africa
13
Middle East and North Africa
13
Guinea
12
Sudan
11
Benin
10
Yemen
10
Afghanistan
8
Central African Republic
8
USA
7
Thailand
7
China
7
Peru
7
Colombia
7
Albania
7
Tajikistan
7
Russia
7
Iraq
6
Lebanon
6
Vietnam
6
Mali
5
Jordan
5
Paraguay
5
Moldova
5
Somalia
4
Turkey
4
Western Pacific Region
4
United Kingdom
4
Egypt
3
Papua New Guinea
3
Argentina
3
Sri Lanka
3
Venezuela
3
Poland
3
Southern Africa
3
Laos
3
Jamaica
3
Mauritius
3
Portugal
3
Togo
2
Singapore
2
North Macedonia
2
Burundi
2
Ecuador
2
Bolivia
2
Mexico
2
Chile
2
Other region
2
Armenia
2
Canada
2
Timor Leste/ East Timor
2
Iran
2
Kyrgyzstan
2
Kazakhstan
2
France
2
Spain
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Gambia
1
Malaysia
1
Dominican Republic
1
Hungary
1
Greece
1
Libya
1
Angola
1
Guatemala
1
Fiji
1
Bhutan
1
Palestine
1
Djibouti
1
Mongolia
1
Qatar
1
Bulgaria
1
Romania
1
Uzbekistan
1
Georgia
1
North America
1
Gabon
1
Turkmenistan
1
Maldives
1
Azerbaijan
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1995
Clinical Guidelines
326
Public Health
208
Women & Child Health
190
Key Resources
126
Capacity Building
60
Pharmacy & Technologies
32
Annual Report MEDBOX
1
Toolboxes
COVID-19
253
Mental Health
251
HIV
246
TB
233
AMR
127
Planetary Health
108
Disability
103
Rapid Response
93
Caregiver
88
NCDs
81
Conflict
74
NTDs
72
Ebola
66
Pharmacy
62
Global Health Education
55
Health Financing Toolbox
49
Refugee
38
Natural Hazards
24
Polio
16
Cholera
15
Zika
13
Specific Hazards
11
Social Ethics
9
Typhoon
3
South Sudan
1
Health Financing
1
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This sourcebook aims to detail why health needs to be part of urban and territorial planning and how to make this happen. It brings together two vital elements we need to build habitable cities on a habitable planet: 1) Processes to guide the development of human settlements – in this document ref...
The introduction of vaccines for coronavirus disease 2019 (COVID-19) added another measure to the existing set of
recommended preventive measures (wearing a mask in public, keeping a distance from other people and regular handwashing). The roll-out of the vaccines, however, raised concerns that vac...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
This technical report presents the epidemiology of human and animal leishmaniases in the EU and its neighbouring countries and concludes that the disease remains widespread and underreported in many countries of southern Europe, northern Africa, and the Middle East and that there is a need to improv...
This Handbook is primarily for educators, to help them learn about mental health issues and better support them in educational environments. The Handbook aims to provide training to teachers, administrators, and people involved in the education of primary school children about the implementation of ...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
The objectives of the meeting were:
1. To update the current status of the disease transmission, country capacities and plans for tackling the disease.
2. To understand the epidemiology including disease distribution and risk, the models
for estimating under-detection, the geographical variati...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
Rabies is a devastating and societally important zoonotic disease, which is transmitted principally to humans through the bite of infected dogs. This acute, progressive viral encephalitis has the highest case fatality of any infectious disease and kills tens of thousands of people annually, with chi...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
To enhance health co-benefits across urban policies which tackle air pollution and climate change, WHO, in cooperation with various international, national, and local partners, implemented the Urban Health Initiative (UHI) pilot project in Accra, Ghana. The Initiative prompted the health sector to u...
Since the beginning of the Ukraine crisis on 24 February 2022, WHO has supported Government-led efforts and initiatives alongside key partners on the ground. Building on efforts to date, and working alongside Bulgaria’s health authorities to bring added value to existing mechanisms, the WHO Countr...
This document aims to assist countries to take the first step towards better considering gender and equity issues in their efforts to tackle antimicrobial resistance (AMR), to inform the implementation of strategies in national action plans and contribute to improved reach and effectiveness of AMR e...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
